37693307|t|The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals.
37693307|a|Voriconazole (VRZ) is a broad-spectrum antifungal medication widely used to treat invasive fungal infections (IFI). The administration dosage and blood concentration of VRZ are influenced by various factors, posing challenges for standardization and individualization of dose adjustments. On the one hand, VRZ is primarily metabolized by the liver, predominantly mediated by the cytochrome P450 (CYP) 2C19 enzyme. The genetic polymorphism of CYP2C19 significantly impacts the blood concentration of VRZ, particularly the trough concentration (Ctrough), thereby influencing the drug's efficacy and potentially causing adverse drug reactions (ADRs). Recent research has demonstrated that pharmacogenomics-based VRZ dose adjustments offer more accurate and individualized treatment strategies for individuals with hepatic insufficiency, with the possibility to enhance therapeutic outcomes and reduce ADRs. On the other hand, the security, pharmacokinetics, and dosing of VRZ in individuals with hepatic insufficiency remain unclear, making it challenging to attain optimal Ctrough in individuals with both hepatic insufficiency and IFI, resulting in suboptimal drug efficacy and severe ADRs. Therefore, when using VRZ to treat IFI, drug dosage adjustment based on individuals' genotypes and hepatic function is necessary. This review summarizes the research progress on the impact of genetic polymorphisms and hepatic insufficiency on VRZ dosage in IFI individuals, compares current international guidelines, elucidates the current application status of VRZ in individuals with hepatic insufficiency, and discusses the influence of CYP2C19, CYP3A4, CYP2C9, and ABCB1 genetic polymorphisms on VRZ dose adjustments and Ctrough at the pharmacogenomic level. Additionally, a comprehensive summary and analysis of existing studies' recommendations on VRZ dose adjustments based on CYP2C19 genetic polymorphisms and hepatic insufficiency are provided, offering a more comprehensive reference for dose selection and adjustments of VRZ in this patient population.
37693307	36	57	hepatic insufficiency	Disease	MESH:D048550
37693307	61	73	voriconazole	Chemical	MESH:D065819
37693307	93	118	invasive fungal infection	Disease	MESH:D000072742
37693307	132	144	Voriconazole	Chemical	MESH:D065819
37693307	146	149	VRZ	Chemical	MESH:D065819
37693307	214	240	invasive fungal infections	Disease	MESH:D000072742
37693307	242	245	IFI	Disease	MESH:D000072742
37693307	301	304	VRZ	Chemical	MESH:D065819
37693307	438	441	VRZ	Chemical	MESH:D065819
37693307	511	537	cytochrome P450 (CYP) 2C19	Gene	1557
37693307	574	581	CYP2C19	Gene	1557
37693307	631	634	VRZ	Chemical	MESH:D065819
37693307	749	771	adverse drug reactions	Disease	MESH:D064420
37693307	773	777	ADRs	Disease	MESH:D064420
37693307	841	844	VRZ	Chemical	MESH:D065819
37693307	943	964	hepatic insufficiency	Disease	MESH:D048550
37693307	1030	1034	ADRs	Disease	MESH:D064420
37693307	1101	1104	VRZ	Chemical	MESH:D065819
37693307	1125	1146	hepatic insufficiency	Disease	MESH:D048550
37693307	1236	1257	hepatic insufficiency	Disease	MESH:D048550
37693307	1262	1265	IFI	Disease	MESH:D000072742
37693307	1316	1320	ADRs	Disease	MESH:D064420
37693307	1344	1347	VRZ	Chemical	MESH:D065819
37693307	1357	1360	IFI	Disease	MESH:D000072742
37693307	1540	1561	hepatic insufficiency	Disease	MESH:D048550
37693307	1565	1568	VRZ	Chemical	MESH:D065819
37693307	1579	1582	IFI	Disease	MESH:D000072742
37693307	1684	1687	VRZ	Chemical	MESH:D065819
37693307	1708	1729	hepatic insufficiency	Disease	MESH:D048550
37693307	1762	1769	CYP2C19	Gene	1557
37693307	1771	1777	CYP3A4	Gene	1576
37693307	1779	1785	CYP2C9	Gene	1559
37693307	1791	1796	ABCB1	Gene	5243
37693307	1822	1825	VRZ	Chemical	MESH:D065819
37693307	1976	1979	VRZ	Chemical	MESH:D065819
37693307	2006	2013	CYP2C19	Gene	1557
37693307	2040	2061	hepatic insufficiency	Disease	MESH:D048550
37693307	2154	2157	VRZ	Chemical	MESH:D065819
37693307	Association	MESH:D065819	5243
37693307	Positive_Correlation	MESH:D065819	MESH:D064420
37693307	Association	MESH:D065819	1559
37693307	Association	MESH:D048550	1557
37693307	Association	MESH:D065819	MESH:D048550
37693307	Association	MESH:D064420	1557
37693307	Negative_Correlation	MESH:D065819	MESH:D000072742
37693307	Association	MESH:D065819	1557

